Contact this trialFirst, we need to learn more about you.
Antimetabolite Chemotherapy
Chemotherapy + Surgery/Radiation for Head and Neck Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial will give carboplatin, nab-paclitaxel, and nivolumab to patients for three cycles of three weeks each. If the tumor responds well, the patient will either have surgery to remove the tumor or radiation therapy. If the tumor does not respond well, the patient will just have radiation therapy. All patients will also receive nivolumab for six months after treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.